Kiyoji Kimura

1.4k total citations
78 papers, 1.1k citations indexed

About

Kiyoji Kimura is a scholar working on Molecular Biology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Kiyoji Kimura has authored 78 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 23 papers in Oncology and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Kiyoji Kimura's work include Acute Lymphoblastic Leukemia research (9 papers), Cancer therapeutics and mechanisms (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Kiyoji Kimura is often cited by papers focused on Acute Lymphoblastic Leukemia research (9 papers), Cancer therapeutics and mechanisms (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Kiyoji Kimura collaborates with scholars based in Japan, United States and Greece. Kiyoji Kimura's co-authors include Kazuo Ota, O Takatani, Ryuzo Ohno, Toshiji Kobayashi, Osahiko Abe, Masao Tanaka, Kazumasa Yamada, Shonen Yoshida, Nobutaka Hattori and T Saito and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer and American Heart Journal.

In The Last Decade

Kiyoji Kimura

69 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kiyoji Kimura Japan 16 452 287 231 147 138 78 1.1k
John J. Costanzi United States 23 509 1.1× 371 1.3× 280 1.2× 150 1.0× 276 2.0× 56 1.5k
Holland Jf United States 19 557 1.2× 468 1.6× 314 1.4× 378 2.6× 111 0.8× 69 1.5k
Y Carcassonne France 17 278 0.6× 179 0.6× 133 0.6× 399 2.7× 134 1.0× 115 1.1k
Martin W. Oster United States 13 404 0.9× 228 0.8× 163 0.7× 212 1.4× 126 0.9× 30 1.4k
Ed Cadman United States 23 696 1.5× 555 1.9× 358 1.5× 182 1.2× 131 0.9× 58 1.6k
Salmon Se United States 16 422 0.9× 474 1.7× 84 0.4× 300 2.0× 62 0.4× 34 1.0k
Ole P. Børmer Norway 20 310 0.7× 447 1.6× 170 0.7× 40 0.3× 279 2.0× 48 1.3k
Daniel L. Kisner United States 13 221 0.5× 284 1.0× 135 0.6× 47 0.3× 116 0.8× 32 928
Gigliola Reato Italy 18 542 1.2× 484 1.7× 175 0.8× 96 0.7× 86 0.6× 36 1.4k
Marianne Noone United States 17 521 1.2× 465 1.6× 112 0.5× 87 0.6× 62 0.4× 22 971

Countries citing papers authored by Kiyoji Kimura

Since Specialization
Citations

This map shows the geographic impact of Kiyoji Kimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiyoji Kimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiyoji Kimura more than expected).

Fields of papers citing papers by Kiyoji Kimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kiyoji Kimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiyoji Kimura. The network helps show where Kiyoji Kimura may publish in the future.

Co-authorship network of co-authors of Kiyoji Kimura

This figure shows the co-authorship network connecting the top 25 collaborators of Kiyoji Kimura. A scholar is included among the top collaborators of Kiyoji Kimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kiyoji Kimura. Kiyoji Kimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tamura, Kazuo, Hisanobu Niitani, Ryuzo Ohno, et al.. (1995). Phase I study of NKT-01. Cancer Chemotherapy and Pharmacology. 36(3). 189–194. 5 indexed citations
2.
Nagura, E, Kiyoji Kimura, Kazumasa Yamada, et al.. (1994). Nation-wide randomized comparative study of doxorubicin, vincristine and prednisolone combination therapy with and without L-asparaginase for adult acute lymphoblastic leukemia. Cancer Chemotherapy and Pharmacology. 33(5). 359–365. 31 indexed citations
3.
Nagura, E, Kiyoji Kimura, Kazumasa Yamada, et al.. (1994). Nation-wide randomized comparative study of doxorubicin, vincristine and prednisolone combination therapy with and without L-asparaginase for adult acute lymphoblastic leukemia. Cancer Chemotherapy and Pharmacology. 33(5). 359–365. 4 indexed citations
4.
5.
Yoshida, Yasuo, et al.. (1991). Relationship between Morphological and Functional Change of the Stomach with Ageing.. Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics. 28(5). 606–610. 2 indexed citations
6.
Hirano, Masami, et al.. (1991). A combination trial of human lymphoblastoid interferon and bestrabucil (KM2210) for adult T-cell leukemia–lymphoma. Cancer. 68(4). 695–698. 17 indexed citations
7.
Morita, Hiroyuki, et al.. (1991). Pharmacokinetics of Cis-Diammine-Dichlor-Platin in a Hemodialysis Patient. Cancer Investigation. 9(6). 629–635. 15 indexed citations
8.
Mizoguchi, Hideaki, Tohru Nakamura, Masaaki Kosaka, et al.. (1991). Treatment of Myelodysplastic Syndromes with Orally Administered l-β-Z)-Arabinofuranosylcytosine-5’-Stearylphosphate. Oncology. 48(6). 451–455. 16 indexed citations
9.
Goto, Tatsuhiko, et al.. (1991). Septicemia in Patients with Solid Cancers in a Japanese Cancer Hospital—The Significance of Candidemia for Cancer Patients. Japanese Journal of Clinical Oncology. 21(1). 52–8. 4 indexed citations
10.
Hiraoka, A, T Masaoka, Hirotoshi Shibata, et al.. (1988). A new nitrosourea derivative for the treatment of chronic myelogenous leukemia. Leukemia Research. 12(6). 487–490. 1 indexed citations
11.
Yamada, Kazumasa, Shigeru Shirakawa, Ryuzo Ohno, et al.. (1987). A phase II study of (2″ R)-4′ -0-tetrahydropyranyladriamycin (THP) in hematological malignancies. Investigational New Drugs. 5(3). 299–305. 2 indexed citations
12.
Kimura, Kiyoji, T Taguchi, I Urushizaki, et al.. (1987). Phase I study of recombinant human tumor necrosis factor. Cancer Chemotherapy and Pharmacology. 20(3). 223–229. 110 indexed citations
13.
Ohno, R, Kiyoji Kimura, Ota K, et al.. (1987). Phase I clinical and pharmacokinetic study of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine.. PubMed. 4(2). 67–73. 2 indexed citations
14.
Motoyoshi, K, F Takaku, T Maekawa, et al.. (1986). Protective effect of partially purified human urinary colony-stimulating factor on granulocytopenia after antitumor chemotherapy.. PubMed. 14(11). 1069–75. 36 indexed citations
15.
Horiuchi, Tadashi, S Suga, Hideo Sawada, et al.. (1985). Basic study for the clinical application of fluoropyrimidines to cancer chemotherapy. Part I. Metabolism of fluoropyrimidines in cancer patients.. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 16(3). 475–487. 3 indexed citations
16.
Tanaka, Masao, Shonen Yoshida, & Kiyoji Kimura. (1983). Mechanism of inhibition of DNA polymerases by 4'-epiadriamycin and 4'-O-tetrahydropyranyladriamycin.. PubMed. 74(6). 829–36. 10 indexed citations
17.
Kimura, Kiyoji. (1976). AN APPROXIMATE ANALYSIS OF FLOW THROUGH RECTANGULAR CHANNEL. Proceedings of the Japan Society of Civil Engineers. 1976(251). 45–57. 2 indexed citations
18.
Hattori, Nobutaka, et al.. (1974). Echographic evaluation of abdominal tumor regression during antineoplastic treatment. Journal of Clinical Ultrasound. 2(2). 131–141. 16 indexed citations
19.
Kobayashi, Toshiji, et al.. (1973). RELATIONSHIP BETWEEN THE AMPLITUDE OF VOLUME PULSE WAVE AND PULSE TRANSMISSION VELOCITY : PROCEEDINGS OF THE 37TH ANNUAL MEETING OF THE JAPANESE CIRCULATION SOCIETY. Japanese Circulation Journal-english Edition. 37(6). 606–607.
20.
Kobayashi, Toshiji, et al.. (1970). Cardiovascular Responses to Intravenous Isoproterenol Infusion in Subjects with and without Left Ventricular Hypertrophy. Japanese Circulation Journal. 34(7). 575–585.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John J. Costanzi Breakdown of academic impact, for papers by Holland Jf Breakdown of academic impact, for papers by Y Carcassonne Breakdown of academic impact, for papers by Martin W. Oster Breakdown of academic impact, for papers by Ed Cadman Breakdown of academic impact, for papers by Salmon Se Breakdown of academic impact, for papers by Ole P. Børmer Breakdown of academic impact, for papers by Daniel L. Kisner Breakdown of academic impact, for papers by Gigliola Reato Breakdown of academic impact, for papers by Marianne Noone
Rankless by CCL
2026